Primary biliary cirrhosis is a frequent indication for liver transplantation. The purpose of this report is to present our experience with liver transplantation for primary biliary cirrhosis. Attention is given to the causes of hepatic dysfunction seen in allografts. In addition, we review the postoperative problems encountered and the quality of life at time of last follow-up in patients with transplants for primary biliary cirrhosis. A total of 97 orthotopic liver transplant procedures were performed in 76 patients with advanced primary biliary cirrhosis at the University of Pittsburgh from March 1980 through September 1985. The transplant operation was relatively easy to perform. The most common technical complications experienced were fragmentation and intramural dissection of the recipient hepatic artery, which required an arterial graft in 20% of the cases. Most of the postoperative mortality occurred in the first 6 mo after transplantation, with an essentially flat actuarial life survival curve from that time point to a projected 5-yr survival of 66%. Common causes of death included rejection and primary graft nonfunction. Thirteen of the 76 patients had some hepatic dysfunction at the time of the last follow-up, although none were jaundiced. Recurrence of primary biliary cirrhosis could not be demonstrated in any of the patients. Antimitochondrial antibody was detected in the serum of almost all of the patients studied postoperatively for it. Most important, almost all of the 52 surviving patients have been rehabilitated socially and vocationally. P rimary biliary cirrhosis (PBC) , or chronic nonsuppurative destructive cholangitis, is a slowly progressive disease of unknown etiology that frequently has associations with other autoimmune diseases (1) (2) (3) . Primary biliary cirrhosis chiefly affects middle-aged women. The diagnosis is established using a combination of clinical findings, particularly chronic cholestasis, the presence of antimitochondrial antibodies (AMAsJ, increased immunoglobulin M levels, and liver biopsy findings of a chronic inflammatory process, particularly lymphocytic infiltration within portal tracts and interlobular bile ducts (when detected earlyJ or an absolute paucity of bile ducts in the cirrhotic stage of the disease (4,5J. Hepatic failure or variceal hemorrhage, or both, are common terminal events (6J.
In the past, medical treatment has consisted of the management of symptoms and the prevention, early recognition, and treatment of systemic complications. More recently, orthotopic liver transplantation (OLT) has been offered as a therapeutic modality to patients with advanced disease (7). However, Neuberger et a1. (8) have reported the recurrence of PBC in 3 of their first 11 liver transplant recipients operated on for PBC. This report somewhat quieted the initial enthusiastic acceptance of liver transplantation for this particular indication. Herein we report the results of hepatic replacement in 76 patients with PBC who were treated between March 1980 and September 1985 at the University of Pittsburgh using cyclosporine and prednisone as the immunosuppressive agents. In cases that manifested postoperative graft dysfunction, attempts were made to de-termine whether or not recurrence of PBC was responsible.
Materials and Methods
The records of 450 liver recipients treated between March 1980 and September 1985 at the University of Colorado (until February 1981) and the University of Pittsburgh (since February 1981) were reviewed. Based on preoperative evaluation and pathologic examination of the resected livers, 76 recipients had PBC as the indication for liver transplantation. The immunosuppression used in all cases was cyclosporine and prednisone (7) to which antilymphocyte globulin or, more recently, the monoclonal antibody OKT 3 (Orthoclone, ORTHO, Pharmaceutical Corporation, Raritan, N.J.) had been added for short intervals to treat rejection episodes (9) . In a few patients with smoldering rejection, low doses of azathioprine were added to the standard combination of cyclosporine and prednisone.
Before OLT, signs and symptoms of PBC had been present for more than 5 yr in 58% of the cases in this series ( Table 1) . At the time of initial evaluation, their ages ranged from 31 to 68 yr. The female/male ratio was -10: 1. The most common symptoms and signs were jaundice, pruritus, gastrointestinal bleeding, and fatigue. Hepatosplenomegaly, ascites, and bone disease were also common (Table 1) .
Operative Procedures and Findings
Liver transplantation was performed using a technique described previously (10) , including venous bypass for the last 61 recipients (11) . Most of the excised livers were considerably larger than normal. Although hilar lymphadenopathy and portal hypertension were common findings at surgery, the hepatectomies were easy to perform, particularly when there had been no previous surgi-cal procedures performed in the right upper quadrant of the recipient. In 2 patients the hepatectomy was complicated by the presence of a surgically created portalsystemic shunt performed 3 and 4 yr before OLT.
Special problems with the rearterialization phases of the OLT procedure were common and were caused by the friability of the recipient's hepatic arteries. which had a tendency for intimal dissection at the site of ligation of arterial branches or where vascular clamps were applied. When dissection was recognized (20% of patients). an interposition graft. using the donor iliac artery (12) . was placed proximal to the infrarenal recipient aorta and was tunneled through the retroperitoneum to the graft hilar area. where it was anastomosed to the graft arterial supply (12) .
The most common biliary reconstruction used was a duct-to-duct anastomosis (86% of patients) over aT-tube stent. The only commonly used alternative method was a choledochojejunostomy to a Roux-en-Y limb (13% of patients) (7) .
Laboratory Data
Total bilirubin. alanine transaminase. alkaline phosphatase, and y-glutamyl transferase were assayed before transplantation. at multiple times after transplantation, and at the time of last follow-up in all surviving recipients (November 1986). After patients were discharged from the hospital. many different laboratories performed these tests and considered them abnormal only if the result was >1.5 mgldl for total bilirubin. 37 lUlL for alanine transaminase. 100 lUlL for alkaline phosphatase, and 44 lUlL for y-glutamyl transferase. The preoperative mean total bilirubin level was 20.1 mgldl (range 1.5-51.0). The single patient with a bilirubin of 1.5 mgldl at the time of OLT was bedridden because of numerous fractures and had had two episodes of variceal gastroesophageal hemorrhage. The mean alkaline phos- Preoperative AMA titers were compared to those obtained postoperatively and at last follow-up as of November 1986 for all surviving patients.
Pathologic Studies
Representative sections of the liver were obtained and examined from both lobes of the resected liver. According to protocol. three hilar sections containing major blood vessels. nerve trunks, and bile ducts were obtained and examined (13) . All sections were stained with hematoxylin and eosin. trichrome. orcein. and rhodanine and were examined by light microscopy. The orcein and rhodanine stains were used for the detection of copperbinding protein and copper within the tissue. respectively. Histologic staging of the native liver (stages I-IV) was determined using established criteria (5, 14) .
A similar protocol was used to histologically assess all failed allografts if either autopsy or retransplantation occurred. Posttransplant biopsy specimens from dysfunctional allografts, particularly those obtained beyond 2 bile ducts and ductular loss. (h) chronic arterial or venous lesions (or both) (15) , and (i) the presence and location of tissue copper and copper-binding protein accumulation.
Rejection was considered to be present if the patient developed postoperative abnormalities in any of the hepatic injury tests performed. whether or not symptoms such as fever. anorexia. and abdominal pain occurred. In most cases. liver biopsy specimens were obtained to either confirm or refute the clinical impression of rejection. Clinical pathologic correlations were attempted systematically. but for differentiating acute or chronic rejection from recurrent PBC. the morphologic criteria summarized in Table 2 were used.
Data Analysis
All data are presented as mean values and range. Patient survival was calculated by the life table method (MOP statistical software. Los Angeles. Calif.). The ,i-test was used to test differences between proportions and the significance of associations. A probability value <0.05 was considered to be significant.
Results

Survival
Fifty-two (68%) of the 76 recipients are alive at follow-ups of 1-6.5 yr. During the 1980-1985 period of case accrual. the survival of patients with PBC was arithmetically better than that of adult recipients with all other indications for the procedure (Figure 1) . This difference was due largely to inclusion in the latter curve of many recipients with diseases such as hepatitis B-positive cirrhosis and hepatic malignancy, which have a high incidence of lethal recurrence within 1-3 yr. For patients with PBC. calculated survival curves appear to be flat after the first full year of survival. with an actuarial 5-yr survival of 66% (Figure 1 ). Patient survival for the PBe group would have been considerably less favorable without the frequent use of retransplantation. In 19 of the 76 recipients (25%) with PBe, retransplantation was performed within a few days to almost 3 yr after the initial graft. In 2 of the cases, three successive transplant procedures were attempted. It is important to note that 9 of the 19 patients (47%) who required retransplantation are included among the 52 current survivors. This retransplantation rate is somewhat greater than that in all other groups, but was possible because of the better overall general condition of PBe patients before initial transplantation as compared with those transplanted for other indications. Moreover, the level of functioning of other critical (nonhepatic) organs such as the lungs and kidney. and the presence or absence of infection-not the severity of the initial or even subsequent hepatic dysfunction-determine whether or not retransplantation is possible. These other factors are less of a problem in patients transplanted for PBe than they are for those transplanted for other indications. Table 3 shows the proportion of patients alive at the time of last follow-up segregated according to duration of survival and six clinical parameters frequently used to categorize patients. No difference in either short-or long-term survival was seen between groups of PBe patients based upon age, total 
Causes for Mortality
The 24 deaths that occurred in this series are summarized in Table 4 . Two patients died during the OLT operation as a result of technical difficulties. Postoperatively. rejection was the single most predominant cause of death, either because retransplantation was not possible (3 cases) or unsuccessful (7 cases). Primary graft nonfunction, although uncommon, was associated with a 100% mortality. 
Morbidity and Rehabilitation
Excluding retransplantation. the postoperative complications experienced by patients transplanted for PBC and requiring surgical intervention are listed in Table 5 . Wound infection was the most common problem followed closely by the need for biliary tract revision.
Seventeen of the 52 surviving patients are currently working full time, 4 are working part time. 2 are partially disabled, and 1 is in the hospital with a seizure disorder (Table 6) .
When the performance status of patients before and after OLT (at the time of last follow-up) are compared. the proportion of those successfully functioning postoperatively (94%) (defined as being either at home caring for themselves or working full or part time) increased significantly (preoperatively LIVER TRANSPLANTATION IN PBC 1211 29%; r = 43.853; P < 0.001). Moreover, when the proportion of patients who were not hospitalized but required some form of care is examined, it can be seen that only 4% of the patients required postoperative care at home compared with 50% preoperatively (r = 43.853; P < 0.001). Consistent with these data are the data concerning the percentage of patients with either bone pain or fractures during the preoperative period (40%), early postoperative period (30%), and late postoperative period (13%) (r = 7.250; P < 0.05). It should be noted. however. that several patients required prolonged (3) (4) (5) (6) mo) postoperative in-hospital rehabilitation because of previous bone disease before their functional status improved postoperatively.
Liver Function
Thirteen of the 52 surviving patients continue to have some abnormalities of liver function (Table  7) . However. the hepatic dysfunction is minor and no patients are jaundiced.
Antimitochondrial Antibody Titers
Sixty-four of the 76 recipients were tested for the presence of AMA before transplantation. Sixtythree (98%) of these patients were found to be positive for this antibody; in 40 the initial titer was >1:80.
Although complete AMA titer data could not be obtained for all ·of the survivors. in 43 of 45 cases evaluated AMAs continued to be detected throughout at the same level or were found to decline Special attention has been paid to the 13 recipients with abnormal liver function. The AMA titer in 10 of these patients has either decreased or remained stable at the pretransplant level. In two other patients. the titer has increased. but the bilirubin level has remained normal and both transaminase and alkaline phosphatase activities have not become abnormal. A liver biopsy specimen obtained from 1 of these 2 patients showed increased iron deposition.
Pathologic Observation
Native livers. Ninety percent of the native Ii vers were stage IV. 9% were stage III. and 1 % was between stage II and III at the time of hepatectomy. Thus. the vast majority of the specimens demonstrated far advanced disease with either macronodular cirrhosis or advanced fibrosis with a paucity of bile ductules in the fibrous septa ( Figures 3A and  3B) . Other conspicuous features included the presence of portal granulomata and lymphoid follicles, marked paraseptal cholestasis with an accumulation of tissue copper and copper-binding protein, an irregular margin between the fibrous septa and regenerative nodules, and the occasional findings of Mallory'S hyaline.
Liver homografts. Grafts failing as a result of chronic rejection were easily separable from native GASTROENTEROLOGY Vol. 94. No.5, Part 1 livers by light microscopy (Figures 3 and 4) . Chronic arterial and venous lesions including subintimal foam cells and myointimal hyperplasia were present only in failed grafts and were never found in native livers ( Figure 3C ). In failed homografts, fibrosis was seen in portal and central areas. but true cirrhosis was never evident ( Figure 3D) . In addition to a relative paucity of inflammatory cells, it was found that granulomas. marginal cholangiolar proliferation, and deposition of tissue copper were absent or uncommon in failed grafts but common in native organs. The cholestasis associated with chronic rejection was predominantly centrilobular, whereas in the native liver it occurred predominantly in a paraseptal (paraportal) location. A common feature of both resected native organs and homografts was the presence of a nonsuppurative destructive cholangitis, which in grafts was thought to be a manifestation of rejection rather than recurrent disease (16) . Biopsy specimens showing acute rejection differed from those of endstage PBC, principally by the presence of a subintimal accumulation of mononuclear cells in the portal and hepatic veins present in rejecting organs but not in native organs. Both acute rejection and PBC are characterized by a mononuclear portal inflammatory infiltrate with destructive duct lesions; however, the inflammatory infiltrate in PBC often extends well into the adjacent hepatic lobule, whereas this is quite unusual in rejection ( Figures 3B and 4) .
Discussion
Primary biliary cirrhosis has become the second most common indication for OLT in adults, being exceeded only by posthepatic cirrhosis as a reason for OLT. The decision about the proper timing of OLT for patients with PBC has been made somewhat less difficult than it is for other indications as a result of the prognostic indices that have been developed using common clinical and pathologic criteria available at most centers (17, 18) . Virtually all of the patients in this series met criteria for advanced disease that predict that without transplantation death is likely within ::0::1 yr (6, 18) . In the future, perhaps many doctors will not allow patients to become mortally ill before performing OL T, as was the case in this series (Tables 1 and 6) . Moreover, it is unlikely that as many patients will have previous upper abdominal surgery such as portal systemic shunts performed before transplantation, as was the case in several of our patients.
The liver transplant operation in patients with PBC is easier to perform than it is for most other adult liver diseases. especially in the absence of previous upper abdominal surgical procedures. The Viguru ]. Endslilge Pile enlarged liver, the usual absence of major collaterals in the hepatic suspensory ligaments and bare areas, the usual normal consistency and configuration of both the suprahepatic inferior vena cava and the portal vein, and the presence of a normal recipient common duct are features present in patients with PEe that make the procedure easier to perform. With the use of the venous bypass, liver replacement in patients with PEe can be accomplished with very little blood loss and with little, if any, physiologic derangement during the operative procedure (10, 11) . A technical problem unique to transplant recipi-. ents with PEe is the fragility of the recipient hepatic arteries. The media and subintima can be separated from the rest of the artery with the slightest trauma including the application of vascular clamps in preparation for an anastomosis and ligation of the gastroduodenal artery or other branches. Intramural dissection of the damaged vessel proximal to or beyond the level of the left gastric and splenic arterial branches can occur. If the diagnosis of a dissection is made, it is necessary to use an iliac graft to prevent subsequent thrombosis (12) . Intimal dissection occurred in 20% of the cases in the present series. The acceptance of a suboptimal arterial supply in cases with dissection is often a prelude to tragedy (19) . Because of the greatly improved quality of life experienced by surviving patients. the use of OL T in PBG has become increasingly attractive. Evaluation of the current experience with OL T for this indication demonstrates that survival and particularly the quality of life of patients is enhanced with OLT compared with standard medical therapy (Tables 3  and 6 ). Most of the mortality experienced after OLT occurs in the first 6 rna with 22 of the 24 deaths occurring during the admission for transplantation. Based on the results reported herein. it appears that transplantation for individuals with advanced PBG is efficacious. Future improvements in the preoperative selection of patients. surgical technique. and postoperative management. as well as more selective or limited use of immunosuppression. should reduce the early surgical mortality and enhance further the acceptability of OL T as a treatment for patients with advanced PBG (9) .
The only disquieting observation relevant to the application of OLT for patients with PBG has come from Neuberger et al. (8) . who reported clinical and histopathologic evidence for recurrent PBG in 3 of 11 patients who underwent liver replacement for PBG using azathioprine and prednisone. The absence of recurrence in the present series with follow-ups of 1-6.5 yr, however. is encouraging. The many histologic similarities between PBG and rejection. as well as graft-versus-host liver disease, may make it difficult to separate disease recurrence from rejection. Our experience suggests that truly recurrent disease is quite unusual. Similar results were reported by Haagsma et al. (20) , who found no evidence of recurrence of PBG in 9 liver transplant recipients followed for at least 1 yr. Attention to the fine details of the type of inflammatory cells found mostly in the portal areas, the degree to which these cells infiltrate the surrounding parenchyma. and the presence or absence of subintimal foamy macrophages and true cirrhosis (regenerative nodules and fibrosis) apparently make it possible to distinguish between these two entities.
It is conceivable that the superior immunosuppression achieved with cyclosporine combined with steroids aborts the underlying autoimmune manifestations of PBG while also controlling the rejection process. The AMA test, which has been considered a relatively specific diagnostic indicator of PBG. does not become negative after transplantation (20, 21) . Moreover, although the AMA titers tend to decline with time after transplantation (Figure 2 ), such changes in individual cases have been unpredict-LIVER TRANSPLANTATION IN PSC 1215 able. It may be that future studies of specific subtypes of AMA in posttransplant patients will provide either more information or new insights into the pathogenesis of this disease. It is conceivable that if recurrence of PBG should occur it will be a slow and gradual event. If recurrence were found to be the case. the process would develop at such a slow pace that transplantation for patients with advanced PBG would still be a reasonable course of action.
Much remains to be learned about both PBG and the process of hepatic rejection. We hope that as experience with both increases. the knowledge available about the two conditions will increase. and that newer and better therapies will be developed.
